Raymond James Financial’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$204K Buy
22,130
+5,000
+29% +$46.1K ﹤0.01% 4468
2025
Q1
$147K Buy
17,130
+1,546
+10% +$13.3K ﹤0.01% 4440
2024
Q4
$167K Buy
+15,584
New +$167K ﹤0.01% 4412